These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7122105)

  • 41. Pharmacological closure of ductus arteriosus in preterm infants using indomethacin.
    Obeyesekere HI; Pankhurst S; Yu VY
    Arch Dis Child; 1980 Apr; 55(4):271-6. PubMed ID: 7416776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. When to treat the patent ductus arteriosus with indomethacin in very-low-birth-weight infants.
    Mahony L; Heymann MA; Carnero V; Brett C; Clyman RI
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():491-4. PubMed ID: 6221636
    [No Abstract]   [Full Text] [Related]  

  • 43. Indomethacin therapy of patent ductus in preterm infants controlled by plasma levels.
    Lewis IG; Harvey DP; Maxwell GM
    Aust Paediatr J; 1985 Aug; 21(3):181-3. PubMed ID: 4062716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacologic Treatment of Patent Ductus Arteriosus in the Preterm Infant.
    Gregory KE
    J Perinat Neonatal Nurs; 2016; 30(1):6-8. PubMed ID: 26813387
    [No Abstract]   [Full Text] [Related]  

  • 45. Symptomatic patent ductus arteriosus in premature infants.
    Hwang B; Hsieh KS; Tsuei DH; Chen SJ; Meng CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Mar; 41(3):201-6. PubMed ID: 3263176
    [No Abstract]   [Full Text] [Related]  

  • 46. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus.
    Betkerur MV; Yeh TF; Miller K; Glasser RJ; Pildes RS
    Pediatrics; 1981 Jul; 68(1):99-102. PubMed ID: 6909683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indomethacin in closure of patent ductus arteriosus.
    Vedanarayanan VV; Verma IC
    Indian J Pediatr; 1981; 48(393):477-80. PubMed ID: 7327640
    [No Abstract]   [Full Text] [Related]  

  • 48. Response of the patent ductus arteriosus to indomethacin treatment.
    Goldberg SJ
    Am J Dis Child; 1987 Mar; 141(3):250. PubMed ID: 3812404
    [No Abstract]   [Full Text] [Related]  

  • 49. Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus.
    Vert P; Bianchetti G; Marchal F; Monin P; Morselli PL
    Eur J Clin Pharmacol; 1980 Jul; 18(1):83-8. PubMed ID: 7398752
    [No Abstract]   [Full Text] [Related]  

  • 50. [Indomethacin and persistent ductus arterious in the pre-term newborn infant with respiratory insufficiency].
    Hurtado del Río D; Holden Barker AM; Segura MA; Lozano González C
    Arch Inst Cardiol Mex; 1981; 51(1):83-8. PubMed ID: 7212861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting oliguria following indomethacin for treatment of patent ductus arteriosus.
    Barrington KJ; Fox M
    Am J Perinatol; 1994 May; 11(3):220-2. PubMed ID: 8048989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atrial natriuretic peptide in the diagnosis of patent ductus arteriosus.
    Weir FJ; Smith A; Littleton P; Carter N; Hamilton PA
    Acta Paediatr; 1992 Sep; 81(9):672-5. PubMed ID: 1421905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patent ductus arteriosus in preterm infants.
    Yu VY
    Med J Aust; 1980 Aug; 2(4):175-6. PubMed ID: 7432277
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacologic treatment of patent ductus arteriosus.
    Friedman WF
    Adv Cardiol; 1979; 26():65-75. PubMed ID: 420062
    [No Abstract]   [Full Text] [Related]  

  • 55. Indomethacin-Responsive Patent Ductus Arteriosus in an Extremely Preterm Infant at 8 Weeks Postnatal Age.
    Chhina AS; Sharma BK; Raja M; Singhal M; Shenoi A
    Indian J Pediatr; 2015 Jul; 82(7):655-6. PubMed ID: 25640067
    [No Abstract]   [Full Text] [Related]  

  • 56. Early indomethacin in patent ductus of the very small premature.
    Burnard ED; Thomas DB; Grattan-Smith P
    Aust Paediatr J; 1982 Mar; 18(1):28-31. PubMed ID: 7103877
    [No Abstract]   [Full Text] [Related]  

  • 57. Decreased plasma glucose after indomethacin therapy in premature infants with patent ductus anteriosus.
    Yeh TF; Raval D; Lilien LD; Srinivasan G; Pildes RS
    Lancet; 1982 Jul; 2(8289):104-5. PubMed ID: 6123794
    [No Abstract]   [Full Text] [Related]  

  • 58. Indomethacin treatment in patent ductus arteriosus. A double-blind study utilizing indomethacin plasma levels.
    Nestrud RM; Hill DE; Arrington RW; Beard AG; Dungan WT; Lau PY; Norton JB; Readinger RI
    Dev Pharmacol Ther; 1980; 1(2-3):125-36. PubMed ID: 6765467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of premature infants with patent ductus arteriosus.
    Merritt TA; Gluck L; Higgins C; Friedman W; Nyhan WL
    West J Med; 1978 Mar; 128(3):212-22. PubMed ID: 636411
    [No Abstract]   [Full Text] [Related]  

  • 60. Plasma indomethacin levels in preterm newborns with symptomatic patent ductus arteriosus: clinical and echocardiographic assessments of response.
    Alpert BS; Lewins MJ; Rowland DW; Grant MJ; Olley PM; Soldin SJ; Swyer PR; Coceani F; Rowe RD
    Adv Prostaglandin Thromboxane Res; 1980; 7():883-5. PubMed ID: 7369052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.